Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 9,567 shares at $70.54 ($688K) on 2015-07-15, disclosed to the SEC on 2015-07-20.
Scheduled sale ($688k) by VP Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.54 | 966 | $68K | 9.9% |
| 2 | $71.45 | 4,241 | $303K | 44.1% |
| 3 | $72.53 | 3,567 | $259K | 37.6% |
| 4 | $73.08 | 793 | $58K | 8.4% |
| Total | $71.90 avg | 9,567 | $688K | 100% |
| Filing → |
| KITE | SELL | 2016-01-19 | $531K | — | Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |